시장조사 보고서 : 세계의 표적 단백질 분해 치료제 시장예측 2021년-2026년

■ 영문 제목 : Global Targeted-protein Degradation Therapeutics Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02312 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 85 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 표적 단백질 분해 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (ARV-110, ARV-471, 기타)와 용도별 시장규모 (암, 신경 과학, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 표적 단백질 분해 치료제 시장 점유율
- 지역별 표적 단백질 분해 치료제 시장규모
- 주요지역의 종류별 시장규모 (ARV-110, ARV-471, 기타)
- 주요지역의 용도별 시장규모 (암, 신경 과학, 기타)
- 미주의 표적 단백질 분해 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 표적 단백질 분해 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 표적 단백질 분해 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 표적 단백질 분해 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 표적 단백질 분해 치료제 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Arvinas, Nurix Therapeutics, Kymera Therapeutics, C4 Therapeutics
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Targeted-protein Degradation Therapeutics will have significant change from previous year. By the most conservative estimates of global Targeted-protein Degradation Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Targeted-protein Degradation Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Targeted-protein Degradation Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
ARV-110
ARV-471
Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Cancer
Neuroscience
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Arvinas
Nurix Therapeutics
Kymera Therapeutics
C4 Therapeutics

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted-protein Degradation Therapeutics Market Size 2016-2026
2.1.2 Targeted-protein Degradation Therapeutics Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Targeted-protein Degradation Therapeutics Segment by Type
2.2.1 ARV-110
2.2.2 ARV-110
2.2.3 Other
2.3 Targeted-protein Degradation Therapeutics Market Size by Type
2.3.1 Global Targeted-protein Degradation Therapeutics Market Size CAGR by Type
2.3.2 Global Targeted-protein Degradation Therapeutics Market Size Market Share by Type (2016-2021)
2.4 Targeted-protein Degradation Therapeutics Segment by Application
2.4.1 Cancer
2.4.2 Neuroscience
2.4.3 Other
2.5 Targeted-protein Degradation Therapeutics Market Size by Application
2.5.1 Global Targeted-protein Degradation Therapeutics Market Size CAGR by Application
2.5.2 Global Targeted-protein Degradation Therapeutics Market Size Market Share by Application (2016-2021)

3 Targeted-protein Degradation Therapeutics Market Size by Players
3.1 Targeted-protein Degradation Therapeutics Market Size Market Share by Players
3.1.1 Global Targeted-protein Degradation Therapeutics Revenue by Players (2019-2021E)
3.1.2 Global Targeted-protein Degradation Therapeutics Revenue Market Share by Players (2019-2021E)
3.2 Global Targeted-protein Degradation Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Targeted-protein Degradation Therapeutics by Regions
4.1 Targeted-protein Degradation Therapeutics Market Size by Regions (2016-2021)
4.2 Americas Targeted-protein Degradation Therapeutics Market Size Growth (2016-2021)
4.3 APAC Targeted-protein Degradation Therapeutics Market Size Growth (2016-2021)
4.4 Europe Targeted-protein Degradation Therapeutics Market Size Growth (2016-2021)
4.5 Middle East & Africa Targeted-protein Degradation Therapeutics Market Size Growth (2016-2021)

5 Americas
5.1 Americas Targeted-protein Degradation Therapeutics Market Size by Country (2016-2021)
5.2 Americas Targeted-protein Degradation Therapeutics Market Size by Type (2016-2021)
5.3 Americas Targeted-protein Degradation Therapeutics Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Targeted-protein Degradation Therapeutics Market Size by Region (2016-2021)
6.2 APAC Targeted-protein Degradation Therapeutics Market Size by Type (2016-2021)
6.3 APAC Targeted-protein Degradation Therapeutics Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Targeted-protein Degradation Therapeutics by Country (2016-2021)
7.2 Europe Targeted-protein Degradation Therapeutics Market Size by Type (2016-2021)
7.3 Europe Targeted-protein Degradation Therapeutics Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Targeted-protein Degradation Therapeutics by Region (2016-2021)
8.2 Middle East & Africa Targeted-protein Degradation Therapeutics Market Size by Type (2016-2021)
8.3 Middle East & Africa Targeted-protein Degradation Therapeutics Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Targeted-protein Degradation Therapeutics Market Forecast
10.1 Global Targeted-protein Degradation Therapeutics Forecast by Regions (2021-2026)
10.1.1 Global Targeted-protein Degradation Therapeutics Forecast by Regions (2021-2026)
10.1.2 Americas Targeted-protein Degradation Therapeutics Forecast
10.1.3 APAC Targeted-protein Degradation Therapeutics Forecast
10.1.4 Europe Targeted-protein Degradation Therapeutics Forecast
10.1.5 Middle East & Africa Targeted-protein Degradation Therapeutics Forecast
10.2 Americas Targeted-protein Degradation Therapeutics Forecast by Countries (2021-2026)
10.2.1 United States Targeted-protein Degradation Therapeutics Market Forecast
10.2.2 Canada Targeted-protein Degradation Therapeutics Market Forecast
10.2.3 Mexico Targeted-protein Degradation Therapeutics Market Forecast
10.2.4 Brazil Targeted-protein Degradation Therapeutics Market Forecast
10.3 APAC Targeted-protein Degradation Therapeutics Forecast by Region (2021-2026)
10.3.1 China Targeted-protein Degradation Therapeutics Market Forecast
10.3.2 Japan Targeted-protein Degradation Therapeutics Market Forecast
10.3.3 Korea Targeted-protein Degradation Therapeutics Market Forecast
10.3.4 Southeast Asia Targeted-protein Degradation Therapeutics Market Forecast
10.3.5 India Targeted-protein Degradation Therapeutics Market Forecast
10.3.6 Australia Targeted-protein Degradation Therapeutics Market Forecast
10.4 Europe Targeted-protein Degradation Therapeutics Forecast by Country (2021-2026)
10.4.1 Germany Targeted-protein Degradation Therapeutics Market Forecast
10.4.2 France Targeted-protein Degradation Therapeutics Market Forecast
10.4.3 UK Targeted-protein Degradation Therapeutics Market Forecast
10.4.4 Italy Targeted-protein Degradation Therapeutics Market Forecast
10.4.5 Russia Targeted-protein Degradation Therapeutics Market Forecast
10.5 Middle East & Africa Targeted-protein Degradation Therapeutics Forecast by Region (2021-2026)
10.5.1 Egypt Targeted-protein Degradation Therapeutics Market Forecast
10.5.2 South Africa Targeted-protein Degradation Therapeutics Market Forecast
10.5.3 Israel Targeted-protein Degradation Therapeutics Market Forecast
10.5.4 Turkey Targeted-protein Degradation Therapeutics Market Forecast
10.5.5 GCC Countries Targeted-protein Degradation Therapeutics Market Forecast
10.6 Global Targeted-protein Degradation Therapeutics Forecast by Type (2021-2026)
10.7 Global Targeted-protein Degradation Therapeutics Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Arvinas
11.1.1 Arvinas Company Information
11.1.2 Arvinas Targeted-protein Degradation Therapeutics Product Offered
11.1.3 Arvinas Targeted-protein Degradation Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Arvinas Main Business Overview
11.1.5 Arvinas Latest Developments
11.2 Nurix Therapeutics
11.2.1 Nurix Therapeutics Company Information
11.2.2 Nurix Therapeutics Targeted-protein Degradation Therapeutics Product Offered
11.2.3 Nurix Therapeutics Targeted-protein Degradation Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Nurix Therapeutics Main Business Overview
11.2.5 Nurix Therapeutics Latest Developments
11.3 Kymera Therapeutics
11.3.1 Kymera Therapeutics Company Information
11.3.2 Kymera Therapeutics Targeted-protein Degradation Therapeutics Product Offered
11.3.3 Kymera Therapeutics Targeted-protein Degradation Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Kymera Therapeutics Main Business Overview
11.3.5 Kymera Therapeutics Latest Developments
11.4 C4 Therapeutics
11.4.1 C4 Therapeutics Company Information
11.4.2 C4 Therapeutics Targeted-protein Degradation Therapeutics Product Offered
11.4.3 C4 Therapeutics Targeted-protein Degradation Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 C4 Therapeutics Main Business Overview
11.4.5 C4 Therapeutics Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Targeted-protein Degradation Therapeutics Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of ARV-110
Table 3. Major Players of ARV-471
Table 4. Major Players of Other
Table 5. Targeted-protein Degradation Therapeutics Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Targeted-protein Degradation Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Targeted-protein Degradation Therapeutics Market Size Market Share by Type (2016-2021)
Table 8. Targeted-protein Degradation Therapeutics Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Targeted-protein Degradation Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Targeted-protein Degradation Therapeutics Market Size Market Share by Application (2016-2021)
Table 11. Global Targeted-protein Degradation Therapeutics Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Players (2019-2021E)
Table 13. Targeted-protein Degradation Therapeutics Key Players Head office and Products Offered
Table 14. Targeted-protein Degradation Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Targeted-protein Degradation Therapeutics Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Targeted-protein Degradation Therapeutics Market Size Market Share by Regions 2016-2021
Table 19. Americas Targeted-protein Degradation Therapeutics Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Targeted-protein Degradation Therapeutics Market Size Market Share by Country (2016-2021)
Table 21. Americas Targeted-protein Degradation Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Targeted-protein Degradation Therapeutics Market Size Market Share by Type (2016-2021)
Table 23. Americas Targeted-protein Degradation Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Targeted-protein Degradation Therapeutics Market Size Market Share by Application (2016-2021)
Table 25. APAC Targeted-protein Degradation Therapeutics Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Targeted-protein Degradation Therapeutics Market Size Market Share by Region (2016-2021)
Table 27. APAC Targeted-protein Degradation Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Targeted-protein Degradation Therapeutics Market Size Market Share by Type (2016-2021)
Table 29. APAC Targeted-protein Degradation Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Targeted-protein Degradation Therapeutics Market Size Market Share by Application (2016-2021)
Table 31. Europe Targeted-protein Degradation Therapeutics Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Targeted-protein Degradation Therapeutics Market Size Market Share by Country (2016-2021)
Table 33. Europe Targeted-protein Degradation Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Targeted-protein Degradation Therapeutics Market Size Market Share by Type (2016-2021)
Table 35. Europe Targeted-protein Degradation Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Targeted-protein Degradation Therapeutics Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Targeted-protein Degradation Therapeutics
Table 44. Key Application and Potential Industries of Targeted-protein Degradation Therapeutics
Table 45. Key Challenges of Targeted-protein Degradation Therapeutics
Table 46. Key Trends of Targeted-protein Degradation Therapeutics
Table 47. Global Targeted-protein Degradation Therapeutics Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Targeted-protein Degradation Therapeutics Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Targeted-protein Degradation Therapeutics Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Targeted-protein Degradation Therapeutics Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Targeted-protein Degradation Therapeutics Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Targeted-protein Degradation Therapeutics Market Size Market Share Forecast by Application (2021-2026)
Table 53. Arvinas Details, Company Type, Targeted-protein Degradation Therapeutics Area Served and Its Competitors
Table 54. Arvinas Targeted-protein Degradation Therapeutics Product Offered
Table 55. Arvinas Targeted-protein Degradation Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Arvinas Main Business
Table 57. Arvinas Latest Developments
Table 58. Nurix Therapeutics Details, Company Type, Targeted-protein Degradation Therapeutics Area Served and Its Competitors
Table 59. Nurix Therapeutics Targeted-protein Degradation Therapeutics Product Offered
Table 60. Nurix Therapeutics Main Business
Table 61. Nurix Therapeutics Targeted-protein Degradation Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Nurix Therapeutics Latest Developments
Table 63. Kymera Therapeutics Details, Company Type, Targeted-protein Degradation Therapeutics Area Served and Its Competitors
Table 64. Kymera Therapeutics Targeted-protein Degradation Therapeutics Product Offered
Table 65. Kymera Therapeutics Main Business
Table 66. Kymera Therapeutics Targeted-protein Degradation Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Kymera Therapeutics Latest Developments
Table 68. C4 Therapeutics Details, Company Type, Targeted-protein Degradation Therapeutics Area Served and Its Competitors
Table 69. C4 Therapeutics Targeted-protein Degradation Therapeutics Product Offered
Table 70. C4 Therapeutics Main Business
Table 71. C4 Therapeutics Targeted-protein Degradation Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. C4 Therapeutics Latest Developments
List of Figures
Figure 1. Targeted-protein Degradation Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Targeted-protein Degradation Therapeutics Market Size Market Share by Type in 2020
Figure 7. Targeted-protein Degradation Therapeutics in Cancer
Figure 8. Global Targeted-protein Degradation Therapeutics Market: Cancer (2016-2021) & ($ Millions)
Figure 9. Targeted-protein Degradation Therapeutics in Neuroscience
Figure 10. Global Targeted-protein Degradation Therapeutics Market: Neuroscience (2016-2021) & ($ Millions)
Figure 11. Targeted-protein Degradation Therapeutics in Other
Figure 12. Global Targeted-protein Degradation Therapeutics Market: Other (2016-2021) & ($ Millions)
Figure 13. Global Targeted-protein Degradation Therapeutics Market Size Market Share by Application in 2020
Figure 14. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Player in 2020
Figure 15. Global Targeted-protein Degradation Therapeutics Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Targeted-protein Degradation Therapeutics Market Size 2016-2021 ($ Millions)
Figure 17. APAC Targeted-protein Degradation Therapeutics Market Size 2016-2021 ($ Millions)
Figure 18. Europe Targeted-protein Degradation Therapeutics Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size 2016-2021 ($ Millions)
Figure 20. Americas Targeted-protein Degradation Therapeutics Market Size Market Share by Country in 2020
Figure 21. Americas Targeted-protein Degradation Therapeutics Market Size Market Share by Type in 2020
Figure 22. Americas Targeted-protein Degradation Therapeutics Market Size Market Share by Application in 2020
Figure 23. United States Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Targeted-protein Degradation Therapeutics Market Size Market Share by Regions in 2020
Figure 27. APAC Targeted-protein Degradation Therapeutics Market Size Market Share by Type in 2020
Figure 28. APAC Targeted-protein Degradation Therapeutics Market Size Market Share by Application in 2020
Figure 29. China Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Targeted-protein Degradation Therapeutics Market Size Market Share by Country in 2020
Figure 36. Europe Targeted-protein Degradation Therapeutics Market Size Market Share by Type in 2020
Figure 37. Europe Targeted-protein Degradation Therapeutics Market Size Market Share by Application in 2020
Figure 38. Germany Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size Market Share by Application in 2020
Figure 46. Egypt Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Targeted-protein Degradation Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 52. APAC Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 53. Europe Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 55. United States Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 56. Canada Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 59. China Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 60. Japan Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 61. Korea Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 63. India Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 64. Australia Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 65. Germany Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 66. France Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 67. UK Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 68. Italy Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 69. Russia Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 70. Spain Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 73. Israel Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Targeted-protein Degradation Therapeutics Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 표적 단백질 분해 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K02312) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 표적 단백질 분해 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 혈장 단백질 치료제 시장예측 2021년-2026년
LPI-2201K02150 / LP Information / 2021년 12월 / 본 조사보고서는 혈장 단백질 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Plasma Protein Therapeutics will have significant change from previous year. By the most conservative estimates of global Plasma Protein Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 25710 million in...

세계의 표적 RNA 시퀀싱 시장예측 2021년-2026년
LPI-2201K02195 / LP Information / 2021년 12월 / 본 조사보고서는 표적 RNA 시퀀싱의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Targeted RNA Sequencing will have significant change from previous year. By the most conservative estimates of global Targeted RNA Sequencing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1377 million in...

세계의 Rho 관련 단백질 키나제 2 시장예측 2021년-2026년
LPI-2201K02164 / LP Information / 2021년 12월 / 본 조사보고서는 Rho 관련 단백질 키나제 2의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Rho Associated Protein Kinase 2 will have significant change from previous year. By the most conservative estimates of global Rho Associated Protein Kinase 2 market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 혈우병 A 및 B 치료제 시장예측 2021년-2026년
LPI-2201K00221 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 A 및 B 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Hemophillia A and B Therapeutics Materials will have significant change from previous year. By the most conservative estimates of global Hemophillia A and B Therapeutics Materials market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in...

세계의 올리고뉴클레오티드 치료제 시장예측 2021년-2026년
LPI-2201K02248 / LP Information / 2021년 12월 / 본 조사보고서는 올리고뉴클레오티드 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Oligonucleotide Therapeutics will have significant change from previous year. By the most conservative estimates of global Oligonucleotide Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3083.2 million in 2020. Over...

세계의 단백질 결정화 및 결정 시장예측 2021년-2026년
LPI-2201K02158 / LP Information / 2021년 12월 / 본 조사보고서는 단백질 결정화 및 결정의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Protein Crystallization and Crystallography will have significant change from previous year. By the most conservative estimates of global Protein Crystallization and Crystallography market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1625...

세계의 소양증 치료제 시장예측 2021년-2026년
LPI-2201K02285 / LP Information / 2021년 12월 / 본 조사보고서는 소양증 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pruritus Therapeutics will have significant change from previous year. By the most conservative estimates of global Pruritus Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 12760 million in 2020. Over...

세계의 마이크로바이옴 치료 및 진단 시장예측 2021년-2026년
LPI-2201K02344 / LP Information / 2021년 12월 / 본 조사보고서는 마이크로바이옴 치료 및 진단의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Microbiome Therapeutics and Diagnostics will have significant change from previous year. By the most conservative estimates of global Microbiome Therapeutics and Diagnostics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX...